Abstract
Treatment strategies based on the association of antiparasitic and immunomodulatory drugs have been considered promising in research for the treatment of Chagas disease. According to recent studies, potent inhibitors of the ergosterol biosynthesis, Posaconazole and Ravuconazole have shown trypanocidal activity with low toxicity in vivo, being considered as alternative drugs in the treatme…